封面
市場調查報告書
商品編碼
1824202

麻醉和呼吸市場 - 預測 2025-2030

Anesthesia and Respiratory Devices Market - Forecasts from 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 151 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

麻醉和呼吸市場規模:

麻醉和呼吸市場預計將從 2025 年的 535.14 億美元成長到 2030 年的 713.44 億美元,複合年成長率為 5.92%。

麻醉和呼吸設備是重要的醫療設備,它們在醫療保健服務中發揮不同但往往互補的功能。麻醉機為接受醫療手術的患者提供可控的麻醉給藥,並維持穩定的麻醉流量,以減輕疼痛和感覺,從而促進外科、醫療和精神科干預。呼吸設備確保手術過程中身體獲得充足的氧氣,為患有氣喘、慢性阻塞性肺病(COPD) 和肺癌等嚴重慢性肺部疾病以及損害人體自然產氧能力的疾病的患者提供必要的支持。

麻醉和呼吸器聯合系統可在手術過程中提供全面的患者照護,減少疼痛並預防呼吸道併發症。這種整合方法可確保各種醫療應用中的病患安全和手術效果。

市場促進因素

慢性病盛行率上升

主要的市場驅動力是全球慢性病發病率的上升,這帶來了對麻醉和呼吸設備的強勁需求。根據美國疾病管制與預防中心的數據,美國每十個成年人中就有六人患有慢性病,每十人中就有四人患有多種慢性病。根據澳洲衛生統計數據,每五名成年人中就有一人患有多種慢性病,每兩次住院治療中就有一次與慢性病的嚴重程度有關。

世界衛生組織 (WHO) 指出,心血管疾病是全球首要死亡原因,佔每年死亡人數的 30% 以上。空氣污染加劇導致肺部疾病和肺癌發生率上升。此外,繁重的工作日程和複雜的生活方式也顯著增加了心血管疾病和需要醫療干預的胃腸道疾病的發病率。

慢性病的日益流行引發了人們對預防和挽救生命的醫療保健的興趣,透過增加對醫療保健的需求,顯著擴大了麻醉和呼吸市場。

醫療基礎建設發展

醫療基礎設施建設和支出的不斷成長,正在加速醫院和醫療單位的建設,從而推動設備需求。基礎設施的擴張需要安裝全面的麻醉和呼吸設備,以支持醫療機構的運作能力,從而為持續的市場成長創造機會。

人口老化

人口老化加劇以及由此帶來的與老齡化相關的健康問題,推動了對用於治療肺部疾病和其他與老齡化相關疾病的呼吸設備的需求。隨著醫療保健系統不斷適應老齡化人口對專業呼吸支持的需求,這一人口趨勢創造了長期的市場擴張前景。

技術創新

業界的技術進步透過增強設備功能、改善患者治療效果以及擴展應用可能性,顯著促進了市場成長。技術創新推動了醫療機構的更換週期和先進解決方案的採用。

區域市場分析

亞太地區成長展望

預計亞太地區麻醉和呼吸市場在預測期內將呈現強勁成長。不斷成長的基礎設施建設促進了最新技術的普及,並帶來了價格實惠、優質的醫療服務,這些因素正在推動該地區的成長。該地區的醫療旅遊活動正在興起,尤其是在泰國、馬來西亞、印度、新加坡和韓國,價格實惠的醫療服務是一大亮點。

亞太地區的醫療保健成本優勢為國際患者節省了巨額醫療費用,且醫療程序和手術費用低於其他新興市場。這種成本競爭力預計將推動亞太地區市場的持續擴張。

預計在預測期內,旨在吸引醫療旅客的優惠政府政策將擴大市場規模。政府增加醫療保健支出,改善國內外病患的基礎設施,將支持醫療旅遊和麻醉及呼吸市場同步成長。

本報告的主要優點

  • 深刻分析:獲得深入的市場洞察,重點關注客戶細分、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場,涵蓋主要地區和新興地區。
  • 競爭格局:了解主要企業所採用的策略策略,並了解正確策略的市場滲透潛力。
  • 市場促進因素和未來趨勢:探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
  • 可行的建議:利用洞察力來制定策略決策,在動態環境中開闢新的業務流和收益。
  • 受眾廣泛:對於新興企業、研究機構、顧問、中小企業和大型企業來說,既有利又划算。

它有什麼用途?

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範與影響、新產品開發、競爭影響

分析範圍

  • 歷史資料(2022-2024)和預測資料(2025-2030)
  • 成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
  • 競爭對手定位、策略和市場佔有率分析
  • 按部門和地區(國家)分類的收益成長和預測分析
  • 公司概況(策略、產品、財務資訊、主要趨勢等)

目錄

第1章執行摘要

第2章市場概述

  • 市場概況
  • 市場定義
  • 分析範圍
  • 細分市場

第3章 經營狀況

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策法規
  • 策略建議

第4章 技術展望

第5章麻醉和呼吸市場(按產品)

  • 介紹
  • 麻醉儀器
  • 麻醉一次性用品
  • 呼吸裝置
  • 一次性呼吸設備
  • 呼吸檢測設備

6. 麻醉和呼吸市場(按最終用戶)

  • 介紹
  • 醫院
  • 門診手術中心(ASC)
  • 居家醫療
  • 診所和診斷中心

7. 麻醉和呼吸市場(按地區)

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 其他

第8章競爭格局及分析

  • 主要企業和策略分析
  • 市佔率分析
  • 企業合併、協議、商業合作
  • 競爭對手儀表板

第9章:公司簡介

  • Smiths Medical
  • General Electric
  • Teleflex Incorporated
  • Getinge AB
  • OSI Systems Inc
  • Koninklijke Philips NV
  • Invacare Corporation
  • ResMed
  • Masimo
  • Fisher & Paykel Healthcare Limited
  • Medtronic

第10章 附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益
  • 分析方法
  • 簡稱

圖表列表

表格列表

簡介目錄
Product Code: KSI061611044

Anesthesia and Respiratory Devices Market Size:

The anesthesia and respiratory devices market is expected to grow from USD 53.514 billion in 2025 to USD 71.344 billion in 2030, at a CAGR of 5.92%.

Anesthesia and respiratory devices represent critical medical equipment serving distinct but often complementary functions in healthcare delivery. Anesthesia devices deliver controlled anesthesia administration to patients undergoing medical procedures, maintaining steady anesthetic flow to reduce pain and sensation for smoother procedural execution across surgical, medical, and psychiatric interventions. Respiratory devices ensure adequate oxygen flow to the body during procedures and provide essential support for patients with severe chronic lung diseases including asthma, chronic obstructive pulmonary disease (COPD), lung cancer, and other conditions compromising natural oxygen generation capacity.

The combination of anesthesia and respiratory devices enables comprehensive patient care during surgical procedures, reducing sensation while preventing respiratory complications. This integrated approach ensures patient safety and procedural efficacy across diverse medical applications.

Market Growth Drivers

Rising Chronic Disease Prevalence

The primary market driver is the escalating incidence of chronic diseases worldwide, creating robust demand for anesthesia and respiratory devices. Chronic disease prevalence has reached significant levels globally, with data from the Center for Disease Control and Prevention indicating that 6 out of 10 adults in America suffer from chronic disease, while 4 out of 10 have multiple chronic conditions. Australian health statistics reveal that 1 in 5 adults suffers from multiple chronic diseases, with 1 in every 2 hospitalizations linked to chronic disease severity.

Cardiovascular disease represents the most common chronic condition globally, with the World Health Organization identifying CVDs as the leading cause of death worldwide, accounting for more than 30% of annual global deaths. Rising air pollution levels have contributed to increased lung disease and lung cancer cases. Additionally, demanding work schedules combined with complex lifestyle factors have significantly contributed to rising CVD and gastric disease incidences requiring medical intervention.

The growing prevalence of chronic diseases necessitates increased medical attention for prevention and life-saving procedures, substantially expanding the anesthesia and respiratory devices market size through heightened healthcare demand.

Healthcare Infrastructure Development

Rising healthcare infrastructure development and expenditure have accelerated hospital and healthcare unit construction, driving equipment demand. This infrastructure expansion creates sustained market growth opportunities as facilities require comprehensive anesthesia and respiratory device installations to support their operational capacity.

Aging Population Demographics

The growing aging population and associated age-related health complexities drive respiratory device demand to address lung diseases and other age-related conditions. This demographic trend creates long-term market expansion prospects as healthcare systems adapt to serve aging populations requiring specialized respiratory support.

Technological Innovation

Technological advancement within the industry contributes significantly to market growth through enhanced device capabilities, improved patient outcomes, and expanded application possibilities. Innovation drives replacement cycles and adoption of advanced solutions across healthcare facilities.

Regional Market Analysis

Asia Pacific Growth Prospects

The Asia Pacific anesthesia and respiratory device market demonstrates robust growth projections during the forecast period. Rising infrastructure development enabling modern technology adoption, coupled with affordable, quality healthcare services, drives regional segment growth. The region has experienced increased medical tourism activity, particularly in Thailand, Malaysia, India, Singapore, and South Korea, where affordable medical services represent primary attractions.

Healthcare cost advantages in the Asia Pacific region provide substantial savings for international patients, with medical procedures and surgeries offering cost reductions compared to other developed markets. This cost competitiveness positions the region for continued market expansion.

Favorable government policies designed to attract medical tourists are anticipated to increase market scope during the forecast period. Rising government healthcare expenditure to improve infrastructure for both domestic and international patients supports concurrent growth in medical tourism and anesthesia and respiratory device markets.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Anesthesia and Respiratory Devices Market Segments:

By Products

  • Anaesthesia Machines
  • Anesthesia Disposables
  • Respiratory Equipment
  • Respiratory Disposable Devices
  • Respiratory Measurement Devices

By End-User

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Homecare Settings
  • Clinics and Diagnostics Centers

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. ANESTHESIA AND RESPIRATORY DEVICES MARKET BY PRODUCTS

  • 5.1. Introduction
  • 5.2. Anaesthesia Machines
  • 5.3. Anesthesia Disposables
  • 5.4. Respiratory Equipment
  • 5.5. Respiratory Disposable Devices
  • 5.6. Respiratory Measurement Devices

6. ANESTHESIA AND RESPIRATORY DEVICES MARKET BY END-USER

  • 6.1. Introduction
  • 6.2. Hospitals
  • 6.3. Ambulatory Surgical Centers (ASCs)
  • 6.4. Homecare Settings
  • 6.5. Clinics and Diagnostics Centers

7. ANESTHESIA AND RESPIRATORY DEVICES MARKET BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. USA
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. United Kingdom
    • 7.4.4. Spain
    • 7.4.5. Others
  • 7.5. Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. UAE
    • 7.5.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. China
    • 7.6.2. India
    • 7.6.3. Japan
    • 7.6.4. South Korea
    • 7.6.5. Indonesia
    • 7.6.6. Thailand
    • 7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. Smiths Medical
  • 9.2. General Electric
  • 9.3. Teleflex Incorporated
  • 9.4. Getinge AB
  • 9.5. OSI Systems Inc
  • 9.6. Koninklijke Philips N.V.
  • 9.7. Invacare Corporation
  • 9.8. ResMed
  • 9.9. Masimo
  • 9.10. Fisher & Paykel Healthcare Limited
  • 9.11. Medtronic

10. APPENDIX

  • 10.1. Currency
  • 10.2. Assumptions
  • 10.3. Base and Forecast Years Timeline
  • 10.4. Key benefits for the stakeholders
  • 10.5. Research Methodology
  • 10.6. Abbreviations

LIST OF FIGURES

LIST OF TABLES